AstraZeneca
(ACC Booth: 1324)
Session Examines Anti-Platelet Therapies During ACC
February 23, 2010 – Experts in anti-platelet therapy will offer their insights and interpretations on emerging agents in comparison to current therapy...
CRESTOR Helps Lower Reduced Risk of Cardiovascular Disease
CRESTOR (rosuvastatin calcium) 20 mg tablets, as an adjunct to diet in adult patients, helps lowered LDL-C, and raise HDL-C to help slow the progression...
 Popular Statin Cleared to Help Reduce Stroke, Heart Attack, Revascularization
February 9, 2010 – The FDA approved CRESTOR (rosuvastatin calcium) to reduce the risk of stroke, myocardial infarction and arterial revascularization procedures...
|
Daiichi Sankyo Inc.
(ACC Booth: 2530)
 Welchol Helps Lower LDL Cholesterol in Pediatric Patients with Hypercholesterolemia
Daiichi Sankyo Inc. offers Welchol (colesevelam HCl) for children and teens with heterozygous familial hypercholesterolemia (heFH).
The October 2009...
|
Eli Lilly and Co.
(ACC Booth: 2730)
 Effient Helps Reduce Stent Thrombosis
Effient (prasugrel) tablets are indicated for the reduction of thrombotic cardiovascular events (including stent thrombosis) in patients with acute coronary...
|
Gilead
(ACC Booth: 2230)
 Studies Show Improvements With Chronic Angina Drug
February 25, 2010 – Recent clinical studies of Ranexa, a prescription medication used to treat adults with chronic angina, indicate several positive benefits...
|
Merck & Co.
(ACC Booth: 1643)
 Drug Attacks Cholesterol In Two Ways
Vytorin is a medicine used to lower levels of total cholesterol, LDL (bad) cholesterol, and fatty substances called triglycerides in the blood. The prescription-only...
Drug Offers Different Way to Fight Cholesterol
Unlike the most common cholesterol-lowering medicines, statins, that work mainly in the liver, a new drug attempts to fight cholesterol by focusing on...
|
Novartis Pharmaceuticals
(ACC Booth: 1044)
Single Tablet Uses Two Drugs to Treat High Blood Pressure
Exforge, a single-tablet combination of two of the most prescribed high blood pressure medicines, is cleared for use in patients who suffer from high blood...
 Tekturna HCT Treats Patients Not Meeting Blood Pressure Goals
Tekturna HCT (aliskiren and hydrochlorothiazide) tablets are indicated for an initial therapy for patients who are likely to need multiple drugs to achieve...
 Valturna Combines Valsartan, Aliskiren for High Blood Pressure Treatment
Valturna (aliskiren and valsartan) is the first and only medicine to target two key points within the renin system, also known as the renin angiotensin...
|
Pfizer
(ACC Booth: 1920)
Intensive Statin Use Shows Reduced Risk of Cardiovascular Events in High-Risk Patients
March 18, 2010 — New data from two subanalyses of the Treating to New Targets (TNT) trial showed an increased dose of atorvastatin calcium (Lipitor), lowered...
 Statin-Based Drug Lowers Bad Cholesterol
An FDA-approved, cholesterol-lowering medication has been proven to significantly reduce the risk of heart attack, stroke, certain kinds of heart surgeries...
 Intravenous Formulation Treats Pulmonary Arterial Hypertension
An intravenous formulation of Revatio (sildenafil) Injection is now available for the treatment of adult patients with pulmonary arterial hypertension...
|
Sanofi-aventis
(ACC Booth: 734)
 Multaq Tablets Treat Atrial Fibrillation and Atrial Flutter
Sanofi-aventis offers Multaq (dronedarone) 400 mg tablets for use in patients with atrial fibrillation (AF) or atrial flutter (AFL).
Multaq is the...
|
Schering-Plough Corp.
Drug Attacks Cholesterol In Two Ways
Vytorin is a medicine used to lower levels of total cholesterol, LDL (bad) cholesterol, and fatty substances called triglycerides in the blood. The prescription-only...
Drug Offers Different Way to Fight Cholesterol
Unlike the most common cholesterol-lowering medicines, statins, that work mainly in the liver, a new drug attempts to fight cholesterol by focusing on...
|
